NMPA Approval

Citicoline Sodium Injection

Approval Number

国药准字H20258050

Company石家庄四药有限公司

Registration Date

April 1, 2025

Previous Approval Numbers

国药准字H20233684

Drug Information

Generic Name

胞磷胆碱钠注射液

Dosage Form

注射剂

Strength

2ml：0.25g（按C₁₄H₂₆N₄O₁₁P₂计）

Drug Type

化学药品

Registration Date

April 1, 2025

Company Information

Applicant Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

Manufacturing Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

胞磷胆碱钠注射液 - NMPA 批准文号 | MedPath